A new study from researchers at King’s College London has split schizophrenia risk into two genetically distinct pathways. One characterised by shared genetic risk with bipolar disorder and associated with higher educational attainment and another unique to schizophrenia itself, associated with lower educational attainment and poorer cognition.
By
NIHR Maudsley BRC at 18 Feb 2026
In the largest genetic study of anxiety disorders to date, new research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London, in partnership with Texas A&M and the Institute of Psychiatric Phenomics and Genomics (IPPG) at LMU Munich, has identified 58 genetic variants associated with anxiety, most of which have not been identified before now.
By
NIHR Maudsley BRC at 3 Feb 2026
Researchers at King’s College London and the University of Florence have, for the first time, identified the specific genetic blueprint of mania, the defining feature of bipolar disorder.
By
NIHR Maudsley BRC at 28 Jan 2026
In 2025, NIHR Maudsley BRC delivered research with real-world impact from evaluating new treatments for depression and migraine to developing innovative approaches to monitoring opioid overdose and diagnosing eating disorders.
By
NIHR Maudsley BRC at 19 Dec 2025
Switching from one selective serotonin reuptake inhibitor (SSRI) to another antidepressant could be used to measure antidepressant non-response, according to new research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London.
By
NIHR Maudsley BRC at 28 May 2025